Is the Internet to Blame for Unsafe Drug Use? - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Is the Internet to Blame for Unsafe Drug Use?
FDA impersonators and counterfeit drugs threaten the public's trust in online pharmacies.

Pharmaceutical Technology
Volume 34, Issue 2, pp. 14

Angie Drakulich
Just before the New Year began, FDA warned the public that criminals were claiming to be agency officials and coercing individuals over the phone to pay fines as high as $250,000 for the illegal purchase of pharmaceuticals. These FDA impersonators somehow obtained records of individuals who had purchased pharmaceuticals online or through telepharmacies and told the individuals that their purchases were illegal. The impersonators asked that a fine be wired, most often to a location in the Dominican Republic.

The international scam is taking advantage of individuals who seek to buy their medication online rather than from a doctor or pharmacy. Often, online drug products are less expensive and provide more convenience and privacy.

The purchase of pharmaceuticals on the Internet is legal with a valid prescription. But in a consumer-safety guide on the subject, FDA warns that not all online pharmacies are US state-licensed, protect personal information, or provide accurate medication for the patient's condition. There's also the possibility of counterfeit or expired drugs being sold.

Fraudulent federal officials capitalizing on the growing business are now giving patients another reason to be paranoid about opting for online pharmacies. The fact is, according to FDA's website, even if a crime was committed, agents and other law enforcement officials are not authorized to impose or collect criminal fines. Only a court can take such action. FDA is working with other government agencies to pursue these criminals, who have also posed as special agents of the FBI, DEA, and more. The scam isn't entirely new. In late 2008, FDA warned of fraudulent special agents that were enticing individuals to buy discounted drugs over the phone—of course, the products were never delivered.

Although the Internet has provided the world with uncountable benefits, it seems to have opened a can of worms for the pharmaceutical industry—and for patients.

Angie Drakulich is managing editor of Pharmaceutical Technology.


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Source: Pharmaceutical Technology,
Click here